DIMITRIEF ALEXANDER purchased $46K of EOSE
DIMITRIEF ALEXANDER purchased 25,000 shares of Eos Energy Enterprises, Inc. (EOSE) at $1.86 on 2026-11-12.
Eos Energy Enterprises, Inc.
Eos Energy develops and manufactures battery storage systems for utilities, microgrids, and commercial and industrial users in the United States. Its offerings include Znyth technology, Z3 battery modules, Eos Indensity and Eos Cube storage architectures, and DawnOS, a battery monitoring and analytics platform. The company also provides project management, commissioning, remote system monitoring, and ongoing maintenance services. Eos Energy is headquartered in Edison, New Jersey.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
DIMITRIEF ALEXANDER purchased 25,000 shares of Eos Energy Enterprises, Inc. (EOSE) at $1.86 on 2026-11-12.
FlexGen Power Systems will integrate MN8 Energy's 86MW Mammoth Solar project in West Virginia, including lithium-ion and zinc-based storage. FlexGen's HybridOS software will manage the project, marking the first utility-scale zinc-based storage deployment in the state. MN8 Energy owns the project, which aims to support local digital infrastructure.
Stifel reduced its price target for Eos Energy Enterprises (EOSE) to $4.00 from $9.00, citing light bookings, while maintaining a Buy rating. EOSE's stock has fallen 90% over the past year. The company reported Q3 2026 revenue of $82.7M, beating estimates, but remains unprofitable. Management narrowed 2026 revenue guidance to $300M-$325M and expects Q4 adjusted gross margin to improve sequentially.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning EOSE (Eos Energy Enterprises, Inc.). Coverage has been balanced: 1 bullish, 0 neutral, and 1 bearish.
Recent EOSE coverage spans earnings, financial news and insider activity.
In the last 30 days, EOSE insiders filed 2 SEC Form 4 transactions — 1 purchase ($47K) and 1 sale ($100K). The most active reporter was DIMITRIEF ALEXANDER with 1 filing. 50% of those filings were made under pre-arranged Rule 10b5-1 plans.
The insider purchase signals confidence from a board member, which could provide modest bullish pressure.
Eos is tied to a new utility-scale storage deployment in West Virginia, which can support pipeline visibility for its zinc-based long-duration storage.
Analyst target cut signals weaker outlook and may trigger further sell pressure.
Earnings beat and strong cash position suggest upside, while backlog decline may temper enthusiasm.
Guidance shows widening losses and modest revenue, likely pressuring the stock.
AlphAI scores every news story that mentions EOSE with an AI model for sentiment and relevance, and aggregates insider trades from Eos Energy Enterprises, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
DIMITRIEF ALEXANDER purchased 25,000 shares of Eos Energy Enterprises, Inc. (EOSE) at $1.86 on 2026-11-12.
FlexGen Power Systems will integrate MN8 Energy's 86MW Mammoth Solar project in West Virginia, including lithium-ion and zinc-based storage. FlexGen's HybridOS software will manage the project, marking the first utility-scale zinc-based storage deployment in the state. MN8 Energy owns the project, which aims to support local digital infrastructure.
Stifel reduced its price target for Eos Energy Enterprises (EOSE) to $4.00 from $9.00, citing light bookings, while maintaining a Buy rating. EOSE's stock has fallen 90% over the past year. The company reported Q3 2026 revenue of $82.7M, beating estimates, but remains unprofitable. Management narrowed 2026 revenue guidance to $300M-$325M and expects Q4 adjusted gross margin to improve sequentially.
Eos Energy (EOSE) reported Q3 2026 record revenue of $82.7M, up 171% YoY, with 23% sequential shipment growth. The company expects ASPs to normalize in Q4. Gross margin improvements are on track, with 50% of the 72-point target achieved. Liquidity is supported by $271M in cash and grants. Frontier Power USA is progressing with financing and pipeline development. EOS sees 3.5GWh of late-stage opportunities, with 43% of backlog attributed to Frontier.
Eos Energy Enterprises (EOSE) expects Q4 2026 adjusted gross margin to be between -25% and -20%, while reaffirming its 2026 revenue guidance of $300M-$325M. The company shared these targets during its Q3 2026 earnings call.
Eos Energy Enterprises, Inc. (EOSE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Eos Energy Enterprises Reports Third Quarter 2026 Revenue of $82.7 Million, Up 171% Year Over Year, with Gross Margin Improving 58 Percentage Points • Delivered record revenue of $82.7 million through deliveries to 10 projects • Gross margin improved 58 percentage points and adju
Eos Energy (EOSE) reported Q3 2026 revenue of $82.7M, up 171% YoY, with improved margins. The company announced a project with MN8 Energy to deliver battery storage for Google's data centers. Eos reaffirmed its full-year revenue outlook of $300M-$350M. The company also received an $87M advance under a U.S. Department of Energy loan.
Eos Energy Enterprises Inc. (EOSE) stock rose 6.3% on October 28, 2026, driven by strong revenue growth and improved margins. The company reported trailing revenue of $114.2M, with Q3 2026 revenue expected to reach $82M–$83M, up 169%–172% year over year. Despite negative margins, EOSE has a solid liquidity position with $300M in cash and short-term investments. The company is focusing on its Thorn Hill facility to improve production and margins.
Truist analyst Christopher Souther reiterated Buy ratings on five clean energy stocks ahead of Q3 earnings, citing strong demand. Clearway Energy (CWEN) is expected to report $522M in Q3 revenue, up 22% YoY. Enlight Renewable Energy (ENLT) is projected to grow Q3 revenue by 27% YoY. First Solar (FSLR) was upgraded to Buy with a $270 price target. Nextpower (NXT) is expected to report $1.1B in FY2027 Q2 revenue, up 22% YoY. Eos Energy (EOSE) reported Q3 revenue of $82M-$83M, up 170% YoY.
EyePoint Pharmaceuticals (EYPT) fell 85% to $0.4 after a failed drug trial, laying off 53% of its workforce. CoreWeave (CRWV) dropped 0.4% to $59.25 due to debt concerns, with analysts cutting price targets. Eos Energy (EOSE) declined 0.5% to $1.72 after lowering revenue expectations.